JS Lilleyman

1.1k total citations · 1 hit paper
13 papers, 926 citations indexed

About

JS Lilleyman is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, JS Lilleyman has authored 13 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Hematology. Recurrent topics in JS Lilleyman's work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). JS Lilleyman is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hemoglobinopathies and Related Disorders (2 papers). JS Lilleyman collaborates with scholars based in United Kingdom, China and United States. JS Lilleyman's co-authors include Lynne Lennard, JL Maddocks and Amin Rostami‐Hodjegan and has published in prestigious journals such as Blood, British Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

JS Lilleyman

13 papers receiving 892 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practical Statistics for Medical Research

1992 616 citations JS Lilleyman Journal of Clinical Pathology profile →

Peers

JS Lilleyman

PHEOH

PPCH

EPIDE

SURGE

HEMAT

Walter W. Tunnessen United States

N. S. Stenhouse Australia

Donna L. Vredevoe United States

Phoebe Lindsey Barton United States

L Naggan Israel

Zachary Johnson Ireland

Zenon Halaba Poland

Christine Sullivan United States

László Kalabay Hungary

Olcay Neyzi Türkiye

Walter W. Tunnessen United States

JS Lilleyman

142 ×0.6

PHEOH

98 ×0.6

PPCH

144 ×1.3

EPIDE

82 ×0.8

SURGE

53 ×0.5

HEMAT

Citations per year, relative to JS Lilleyman JS Lilleyman (= 1×) peers Walter W. Tunnessen

Countries citing papers authored by JS Lilleyman

Since Specialization

Citations

This map shows the geographic impact of JS Lilleyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JS Lilleyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JS Lilleyman more than expected).

Fields of papers citing papers by JS Lilleyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JS Lilleyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JS Lilleyman. The network helps show where JS Lilleyman may publish in the future.

Co-authorship network of co-authors of JS Lilleyman

This figure shows the co-authorship network connecting the top 25 collaborators of JS Lilleyman. A scholar is included among the top collaborators of JS Lilleyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JS Lilleyman. JS Lilleyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Lennard, Lynne, et al.. (1995). Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?. British Journal of Cancer. 72(4). 1004–1006. 63 indexed citations

2.

Rostami‐Hodjegan, Amin, Lynne Lennard, & JS Lilleyman. (1995). The accumulation of mercaptopurine metabolites in age fractionated red blood cells.. British Journal of Clinical Pharmacology. 40(3). 217–222. 24 indexed citations

3.

Lilleyman, JS. (1992). Practical Statistics for Medical Research. Journal of Clinical Pathology. 45(4). 368–368. 616 indexed citations breakdown →

4.

Lilleyman, JS. (1991). Hematologic Disorders in Maternal-Fetal Medicine. Journal of Clinical Pathology. 44(8). 704.1–704. 2 indexed citations

5.

Lilleyman, JS. (1991). Leukaemia Diagnosis. A Guide to the FAB Classification. Journal of Clinical Pathology. 44(10). 879.2–879. 4 indexed citations

6.

Lilleyman, JS. (1990). Atlas of Human Parasitology. 3rd ed. Journal of Clinical Pathology. 43(11). 967.1–967. 9 indexed citations

7.

Lilleyman, JS. (1990). De Gruchy's Clinical Haematology in Medical Practice. Journal of Clinical Pathology. 43(4). 352.2–352. 32 indexed citations

8.

Lilleyman, JS. (1989). Developmental and Neonatal Haematology. Journal of Clinical Pathology. 42(2). 220.1–220. 1 indexed citations

9.

Lilleyman, JS. (1988). Immunobiology of Cancer and AIDS: Etiology, Diagnosis, and Management. Journal of Clinical Pathology. 41(10). 1140.1–1140. 1 indexed citations

10.

Lilleyman, JS. (1987). Color Atlas of Clinical Hematology. Journal of Clinical Pathology. 40(5). 591.2–591. 7 indexed citations

11.

Lennard, Lynne, et al.. (1983). Childhood leukaemia: a relationship between intracellular 6‐ mercaptopurine metabolites and neutropenia.. British Journal of Clinical Pharmacology. 16(4). 359–363. 130 indexed citations

12.

Lilleyman, JS, et al.. (1977). Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine. Blood. 49(4). 559–562. 1 indexed citations

13.

Lilleyman, JS, et al.. (1977). Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine. Blood. 49(4). 559–562. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact